Addition of Radiotherapy for DCIS Cuts Risk for Subsequent Cancer
FRIDAY, Oct. 16, 2020 -- For women with ductal carcinoma in situ (DCIS), the risk for developing subsequent ipsilateral in situ (iDCIS) and invasive breast cancer (iBC) is lower for those receiving breast-conserving surgery (BCS) and radiotherapy... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 16, 2020 Category: Pharmaceuticals Source Type: news
Study Helps Gauge Long-term Risks for Women With DCIS Study Helps Gauge Long-term Risks for Women With DCIS
New research helps clarify the long-term risk for invasive breast cancer in women with ductal carcinoma (DCIS) in situ who opt for breast-conserving surgery alone or with radiotherapy.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - October 8, 2020 Category: Pathology Tags: Hematology-Oncology News Source Type: news
Breast cancer surgery type, quality of life among younger women
(JAMA Network) Researchers investigated differences in quality of life and other outcomes (including physical functioning, body image, sexual health, anxiety and depressive symptoms) by type of breast cancer surgery (such as mastectomy or breast conserving surgery) in women 40 and younger. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 16, 2020 Category: Cancer & Oncology Source Type: news
‘Could It Work as a Cure? Maybe.’ A Herbal Remedy for Coronavirus Is a Hit in Africa, But Experts Have Their Doubts
On April 20, the president calls a press conference to announce a breakthrough in the fight against COVID-19. It’s a new use for an old malaria treatment, he says, one that is seeing miraculous results among the country’s most ill patients. It’s so safe that even schoolchildren could take it. In fact, he urges them to do so daily, as a preventative. He admits that he, too, is taking the medicine.
No, this is not the President of the United States touting an unproven remedy for a virus that has infected nearly 5 million people worldwide. It is Madagascar’s President Andry Rajoelina, who is just as wi...
Source: TIME: Health - May 22, 2020 Category: Consumer Health News Authors: Aryn Baker Tags: Uncategorized COVID-19 overnight Source Type: news
Medtech Perseveres During COVID-19
The COVID-19 pandemic is “an unprecedented crisis, and we’ve never seen anything like it,†Pat Shafer, managing director in Grant Thornton's healthcare and life sciences industry business, told MD+DI recently.
Judging from the amount of stories MD+DI has published alone in the last several weeks on the rapid responses from many medical device and diagnostics companies as well as industry suppliers, manufacturers are working quickly toward several potential solutions.
The medical device industry has been very agile in responding to the pandemic, Shafer said. â€...
Source: MDDI - April 21, 2020 Category: Medical Devices Authors: Daphne Allen Tags: Business Source Type: news
High-res imaging with elastography may accurately detect breast cancer in surgical margins
(American Association for Cancer Research) A high-resolution, three-dimensional imaging technique, when combined with quantitative measurement of tissue elasticity, could accurately detect cancer within the resected margins of surgical specimens taken from patients undergoing breast-conserving surgery. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 15, 2020 Category: Cancer & Oncology Source Type: news
Breast Conservation After Neoadjuvant Chemotherapy Less Common in US Than Elsewhere Breast Conservation After Neoadjuvant Chemotherapy Less Common in US Than Elsewhere
Neoadjuvant systemic therapy can facilitate breast conservation in certain women with stage II and III operable breast cancer. But compared to other countries, significantly fewer women in the United States make such a choice.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 15, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Despite effective therapy, US rate of breast conservation lower than other countries
(Brigham and Women's Hospital) Patients treated in Europe or Asia were 2.6 times as likely to undergo breast conserving therapy rather than a mastectomy compared to those treated in North America when adjusted for clinically significant factors. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 8, 2020 Category: Cancer & Oncology Source Type: news
Breast-conserving treatment without surgery not supported at this time
(NRG Oncology) Results from NRG Oncology's BR005 study show that breast-conserving treatment without surgery cannot be recommended, based on the study criteria of clinical complete response, radiological complete response (rCR)/near rCR, and negative tumor bed biopsies. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 13, 2019 Category: Cancer & Oncology Source Type: news
Accelerated PBI not equivalent, but close, to WBI to control ipsilateral breast tumor recurrence
(NRG Oncology) Long-term results from the NRG Oncology clinical trial NSABP B-39/RTOG 0413 comparing whole-breast irradiation (WBI) to accelerated partial-breast irradiation (APBI) indicated that, although the absolute difference between treatment was less than 1%, APBI did not meet the criteria for equivalence to WBI in controlling ipsilateral breast tumor recurrence (IBTR) after breast-conserving therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 5, 2019 Category: Cancer & Oncology Source Type: news
Hologic Renews Focus for Breast Health with CE Mark Extension
Hologic is wasting little time putting the focus back on its breast health offerings. The Marlborough, MA-based company received an extension of a CE mark for the LOCalizer radiofrequency identification (RFID) tag for long-term placement.
The tag can now be implanted more than 30 days before a breast-conserving surgery, providing even greater flexibility and convenience to patients and providers.
The LOCalizer wire-free guidance system is a non-radioactive, radiofrequency localization system designed for precise marking and targeting of lesions in breast-conserving surgery. It was designed to replace the traditional wire-g...
Source: MDDI - December 2, 2019 Category: Medical Devices Authors: Omar Ford Tags: Regulatory and Compliance Source Type: news
Breast cancer recurrence after lumpectomy & RT is treatable with localized RT without mastectomy
(NRG Oncology) Approximately 10% of breast cancer patients treated with lumpectomy (breast-conserving surgery [BCS]) and whole-breast radiation (WBI) will have a subsequent in-breast local recurrence of cancer (IBTR) when followed long term. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 22, 2019 Category: Cancer & Oncology Source Type: news
No Benefit Seen for SLNB in BCS for DCIS in Older Women
Long - term outcomes similar with, without sentinel lymph node biopsy in breast - conserving surgery (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 31, 2019 Category: Cancer & Oncology Tags: Gynecology, Oncology, Surgery, Geriatrics, Journal, Source Type: news
No Benefit Seen for SLNB in BCS for DCIS in Older Women
THURSDAY, Oct. 31, 2019 -- For older patients with ductal carcinoma in situ (DCIS) who undergo breast-conserving surgery (BCS), sentinel lymph node biopsy (SLNB) is not associated with improvements in long-term outcomes, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 31, 2019 Category: Pharmaceuticals Source Type: news
Treatment of Male Breast Cancer Has Evolved From 2004 to 2014
Significant increases seen in total mastectomy, radiotherapy after breast conservation, endocrine tx (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 7, 2019 Category: Cancer & Oncology Tags: Family Medicine, Internal Medicine, Nursing, Oncology, Journal, Source Type: news
